Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14580 | 694 | 40.0 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
796 | 11443 | DRY POWDER INHALER//MUCOADHESION//JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NOVEL DRUG VACCINE DELIVERY SYST IL | Address | 17 | 68% | 2% | 15 |
2 | INFECT DIS ANIM MODELS GRP | Address | 3 | 100% | 0% | 3 |
3 | LIPOSOMAL ANTIBIOTIC | Author keyword | 3 | 100% | 0% | 3 |
4 | ZINC CITRATE PARTICLES | Author keyword | 3 | 100% | 0% | 3 |
5 | AEROSOLIZED LIPOSOMES | Author keyword | 2 | 67% | 0% | 2 |
6 | CAPREOMYCIN SULFATE | Author keyword | 2 | 50% | 0% | 3 |
7 | LIPOSOME TARGETING | Author keyword | 2 | 33% | 1% | 4 |
8 | ANIONIC LIPOSOMES | Author keyword | 2 | 22% | 1% | 6 |
9 | BRUCELLA INFECTED MICE | Author keyword | 1 | 100% | 0% | 2 |
10 | HYDROPHOBIC ION PAIR | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPOSOMAL ANTIBIOTIC | 3 | 100% | 0% | 3 | Search LIPOSOMAL+ANTIBIOTIC | Search LIPOSOMAL+ANTIBIOTIC |
2 | ZINC CITRATE PARTICLES | 3 | 100% | 0% | 3 | Search ZINC+CITRATE+PARTICLES | Search ZINC+CITRATE+PARTICLES |
3 | AEROSOLIZED LIPOSOMES | 2 | 67% | 0% | 2 | Search AEROSOLIZED+LIPOSOMES | Search AEROSOLIZED+LIPOSOMES |
4 | CAPREOMYCIN SULFATE | 2 | 50% | 0% | 3 | Search CAPREOMYCIN+SULFATE | Search CAPREOMYCIN+SULFATE |
5 | LIPOSOME TARGETING | 2 | 33% | 1% | 4 | Search LIPOSOME+TARGETING | Search LIPOSOME+TARGETING |
6 | ANIONIC LIPOSOMES | 2 | 22% | 1% | 6 | Search ANIONIC+LIPOSOMES | Search ANIONIC+LIPOSOMES |
7 | BRUCELLA INFECTED MICE | 1 | 100% | 0% | 2 | Search BRUCELLA+INFECTED+MICE | Search BRUCELLA+INFECTED+MICE |
8 | HYDROPHOBIC ION PAIR | 1 | 50% | 0% | 2 | Search HYDROPHOBIC+ION+PAIR | Search HYDROPHOBIC+ION+PAIR |
9 | LOW DOSE AEROSOL INFECTION | 1 | 100% | 0% | 2 | Search LOW+DOSE+AEROSOL+INFECTION | Search LOW+DOSE+AEROSOL+INFECTION |
10 | MICELLE FORMING POLYMER | 1 | 100% | 0% | 2 | Search MICELLE+FORMING+POLYMER | Search MICELLE+FORMING+POLYMER |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SKIN ASSOCIATED BACTERIA | 31 | 92% | 2% | 12 |
2 | INHALABLE MICROPARTICLES | 25 | 65% | 3% | 24 |
3 | RESPIRABLE PLGA MICROSPHERES | 23 | 64% | 3% | 23 |
4 | ENCAPSULATED ANTITUBERCULAR DRUGS | 16 | 61% | 2% | 17 |
5 | ENTRAPPED AMPICILLIN | 15 | 77% | 1% | 10 |
6 | ENCAPSULATED TOBRAMYCIN | 15 | 88% | 1% | 7 |
7 | RAT LUNG TISSUE | 12 | 86% | 1% | 6 |
8 | ENCAPSULATED GENTAMICIN | 11 | 67% | 1% | 10 |
9 | ENCAPSULATED AMIKACIN | 11 | 78% | 1% | 7 |
10 | BISMUTH ETHANEDITHIOL | 9 | 83% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Liposomes as delivery systems for antibiotics | 2010 | 74 | 103 | 60% |
Lipid and polymer nanoparticles for drug delivery to bacterial biofilms | 2014 | 10 | 117 | 42% |
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications | 2000 | 141 | 105 | 57% |
Pulmonary drug delivery systems for tuberculosis treatment | 2015 | 1 | 83 | 47% |
Biodegradable nanoparticles for intracellular delivery of antimicrobial agents | 2014 | 7 | 146 | 47% |
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases | 2013 | 17 | 97 | 36% |
Development of Nanoparticles for Antimicrobial Drug Delivery | 2010 | 131 | 82 | 22% |
Inhaled drug therapy for treatment of tuberculosis | 2011 | 34 | 94 | 40% |
Delivery of antibiotics with polymeric particles | 2014 | 10 | 160 | 27% |
Nanostructured drug delivery for better management of tuberculosis | 2014 | 7 | 123 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NOVEL DRUG VACCINE DELIVERY SYST IL | 17 | 68% | 2.2% | 15 |
2 | INFECT DIS ANIM MODELS GRP | 3 | 100% | 0.4% | 3 |
3 | BACTERIAL INFECT ANTIMICROBIAL THER IES | 1 | 50% | 0.1% | 1 |
4 | BENJAMIN FRANKLIN UNIV CLIN | 1 | 50% | 0.1% | 1 |
5 | BIOMAT REGENERAT THER IES | 1 | 50% | 0.1% | 1 |
6 | BIOTECHNOL SUPRAMOL LIPID AGGREGATES | 1 | 50% | 0.1% | 1 |
7 | INFECT DIS PK PD | 1 | 50% | 0.1% | 1 |
8 | PHARM PHARMACEUT TOXICOL | 1 | 50% | 0.1% | 1 |
9 | PHARMACOL CLIN ANALYT TOXICOL SERV | 1 | 50% | 0.1% | 1 |
10 | SKIN BARRIER | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000122002 | RIFABUTIN//KRM 1648//RIFALAZIL |
2 | 0.0000119680 | INHALED INSULIN//PULMONARY ABSORPTION//PULMONARY DELIVERY |
3 | 0.0000115383 | DRY POWDER INHALER//DRY POWDER INHALATION//ADV DRUG DELIVERY GRP |
4 | 0.0000109222 | LIPOSOME//THERMOSENSITIVE LIPOSOMES//IMMUNOLIPOSOMES |
5 | 0.0000087255 | MULTIVESICULAR LIPOSOMES//MREV//MULTIVESICULAR LIPOSOME |
6 | 0.0000085626 | ISONIAZID//ISONICOTINYL HYDRAZONE//ACETYLISONIAZID |
7 | 0.0000080673 | NANOCAPSULES//LIPID CORE NANOCAPSULES//POLYALKYLCYANOACRYLATE |
8 | 0.0000079619 | EARLY BACTERICIDAL ACTIVITY//DELAMANID//BEDAQUILINE |
9 | 0.0000071960 | NIOSOMES//ETHOSOMES//PRONIOSOMES |
10 | 0.0000068161 | AMPHOTERICIN B//AMPHOTERICIN B LIPID COMPLEX//AMPHOTERICIN B COLLOIDAL DISPERSION |